Washington Trust’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Washington Trust’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16,000	Closed	-$14K	–	247
2019 Q2	$14K	Hold	16,000	–	–	﹤0.01%	237
2019 Q1	$15K	Sell	16,000 -3,000	-16%	-$3.16K	﹤0.01%	219
2018 Q4	$14K	Hold	19,000	–	–	﹤0.01%	218
2018 Q3	$41K	Hold	19,000	–	–	﹤0.01%	227
2018 Q2	$95K	Hold	19,000	–	–	0.01%	324
2018 Q1	$74K	Hold	19,000	–	–	﹤0.01%	214
2017 Q4	$51K	Sell	19,000 -12,400	-39%	-$36.3K	﹤0.01%	221
2017 Q3	$100K	Hold	31,400	–	–	0.01%	211
2017 Q2	$104K	Buy	+31,400	New	+$122K	0.01%	206
2017 Q1	–	Sell	-31,400	Closed	-$128K	–	224
2016 Q4	$128K	Sell	31,400 -9,662	-24%	-$40.1K	0.01%	207
2016 Q3	$154K	Hold	41,062	–	–	0.01%	203
2016 Q2	$140K	Hold	41,062	–	–	0.01%	202
2016 Q1	$218K	Hold	41,062	–	–	0.01%	193
2015 Q4	$505K	Hold	41,062	–	–	0.03%	141
2015 Q3	$599K	Hold	41,062	–	–	0.04%	136
2015 Q2	$801K	Hold	41,062	–	–	0.05%	133
2015 Q1	$743K	Hold	41,062	–	–	0.05%	133
2014 Q4	$969K	Hold	41,062	–	–	0.07%	122
2014 Q3	$994K	Hold	41,062	–	–	0.07%	115
2014 Q2	$1.15M	Hold	41,062	–	–	0.08%	107
2014 Q1	$1.4M	Buy	41,062 +6,400	+18%	+$219K	0.11%	106
2013 Q4	$662K	Hold	34,662	–	–	0.05%	132
2013 Q3	$562K	Buy	34,662 +8,696	+33%	+$101K	0.05%	136
2013 Q2	$273K	Buy	+25,966	New	+$304K	0.02%	168

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Washington Trust's CTIC Position: Q3 2019 in Review

Washington Trust sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2019, closing a stake of 16,000 shares — an estimated $14K sold.

Washington Trust first reported a position in CTIC in Q2 2013 and held it in 24 quarters. The position peaked at $1.4M in Q1 2014. 43 funds tracked by Wall St. Rank hold CTIC as of Q3 2019.

Washington Trust reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2019 after selling out during the quarter.
Washington Trust sold 16,000 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2019, an estimated $14K.
Washington Trust first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 24 quarters.
Washington Trust's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.4M in Q1 2014.
43 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2019.

Based on Washington Trust's 13F filing for Q3 2019, filed 6 Nov 2019.